Hemenway Trust Hemenway Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$454K Hold
3,850
0.04% 83
2025
Q4
$631K Sell
3,850
-200
-5% -$31.3K 0.05% 78
2025
Q3
$541K Sell
4,050
-200
-5% -$24.3K 0.04% 82
2025
Q2
$529K Hold
4,250
0.04% 85
2025
Q1
$541K Hold
4,250
0.04% 80
2024
Q4
$612K Hold
4,250
0.05% 77
2024
Q3
$632K Hold
4,250
0.05% 77
2024
Q2
$536K Hold
4,250
0.05% 84
2024
Q1
$782K Sell
4,250
-250
-6% -$47.6K 0.07% 71
2023
Q4
$809K Hold
4,500
0.08% 67
2023
Q3
$716K Sell
4,500
-500
-10% -$81.7K 0.08% 75
2023
Q2
$707K Sell
5,000
-200
-4% -$32.1K 0.07% 80
2023
Q1
$875K Sell
5,200
-200
-4% -$35.7K 0.09% 71
2022
Q4
$914K Hold
5,400
0.1% 74
2022
Q3
$1.01M Sell
5,400
-743
-12% -$157K 0.12% 67
2022
Q2
$998K Hold
6,143
0.11% 66
2022
Q1
$1.16M Buy
+6,143
New +$1.17M 0.11% 66

Other funds holding RGEN

Hemenway Trust Hemenway Trust's RGEN Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust held its Repligen (RGEN) position steady in Q1 2026 at 3,850 shares worth $454K. The position accounts for 0.04% of the portfolio, ranked #83.

Hemenway Trust Hemenway Trust first reported a position in RGEN in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.16M in Q1 2022. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Hemenway Trust Hemenway Trust held 3,850 shares of Repligen worth $454K as of Q1 2026.
  • Hemenway Trust Hemenway Trust left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.04% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #83 holding.
  • Hemenway Trust Hemenway Trust first reported a position in Repligen in Q1 2022 and has held it in 17 quarters since.
  • Hemenway Trust Hemenway Trust's Repligen position peaked at $1.16M in Q1 2022.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.